Dow Up 0.17% Nasdaq Up 0.29%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
0.91 0.00(0.25%) Aug 26, 4:00PM EDT
Prev Close:0.91
Open:0.92
Bid:0.85 x 5500
Ask:4.98 x 100
1y Target Est:3.50
Beta:1.07
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:0.91 - 0.94
52wk Range:0.65 - 4.00
Volume:268,564
Avg Vol (3m):679,345
Market Cap:55.47M
P/E (ttm):N/A
EPS (ttm):-0.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMUC

Comparison

Symbol% ChgMkt Cap
IMUCUp 0.25%55.47M
AGEN198.07M
DNDN217.60M
STML149.66M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback